NL-OMON36055已完成2 期
A prospective trial with ketoconazole and octreotide combination therapy for treatment of Cushing*s disease. - Ketoconazole/octreotide therapy for Cushing's disease.
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Biochemically confirmed ACTH dependent Cushing's syndrome originating from a pituitary adenoma (either de novo, recurrent or residual)
排除标准
- •Impaired liver function
- •Renal insufficiency
- •Symptomatic cholelithiasis
- •History of pituitary irradiation
研究者
相似试验
进行中（未招募）
不适用
A study with ketoconazole and octreotide combination therapy for treatment of Cushing’s disease.Cushing's disease (which is caused by an ACTH producing pituitary adenoma)MedDRA version: 14.0Level: LLTClassification code 10011651Term: Cushing's diseaseSystem Organ Class: 10014698 - Endocrine disordersEUCTR2011-003264-77-NLErasmus MC
招募中
不适用
Ketoconazole and octreotide as medical treatment for Cushing's disease.Cushing's diseaseZiekte van CushingNL-OMON20862Erasmus MC Rotterdam10
进行中（未招募）
不适用
Ketoconazole in Locally Advanced or Disseminated Granulosa Cell Tumour of Ovary.EUCTR2012-001948-21-ESGrupo Español de Tumores Huérfanos e Infrecuentes
已完成
3 期
Evaluation of the effectiveness of climbazole shampoo treatment.tinea versicolor.Pityriasis versicolorB36.0IRCT20190811044510N1Kerman University of Medical Sciences60
已完成
1 期
Effect of Ketoconazole on Regorafenib (BAY73-4506) PharmacokineticsPharmacokineticsNCT01318265Bayer24